Pages that link to "Q43247372"

The following pages link to Aliskiren prevents cardiovascular complications and pancreatic injury in a mouse model of obesity and type 2 diabetes (Q43247372):

Displaying 33 items.

• Animal models of metabolic syndrome: a review (Q28072861) (← links)
• Aliskiren-attenuated myocardium apoptosis via regulation of autophagy and connexin-43 in aged spontaneously hypertensive rats. (Q34011428) (← links)
• Approach to assessing determinants of glucose homeostasis in the conscious mouse (Q34205173) (← links)
• Rodent models for metabolic syndrome research (Q34479248) (← links)
• Renin-angiotensin system blockers protect pancreatic islets against diet-induced obesity and insulin resistance in mice (Q34872407) (← links)
• DPP-4 inhibition with linagliptin ameliorates cognitive impairment and brain atrophy induced by transient cerebral ischemia in type 2 diabetic mice (Q35690114) (← links)
• Direct renin inhibition modulates insulin resistance in caveolin-1-deficient mice (Q36456701) (← links)
• Multidisciplinary pharmacotherapeutic options for nonalcoholic Fatty liver disease (Q36470320) (← links)
• TRPV1-mediated UCP2 upregulation ameliorates hyperglycemia-induced endothelial dysfunction (Q36816043) (← links)
• Cardiovascular changes in animal models of metabolic syndrome (Q36825744) (← links)
• Hepatic extracellular signal-regulated kinase 2 suppresses endoplasmic reticulum stress and protects from oxidative stress and endothelial dysfunction (Q37310401) (← links)
• Myocardial tissue remodeling in adolescent obesity (Q37310497) (← links)
• Coronary endothelial dysfunction and mitochondrial reactive oxygen species in type 2 diabetic mice (Q37341923) (← links)
• Aliskiren improves vascular smooth muscle function in the skin microcirculation of type 2 diabetic patients with normal renal function (Q37619165) (← links)
• Direct renin inhibition with aliskiren protects against myocardial ischemia/reperfusion injury by activating nitric oxide synthase signaling in spontaneously hypertensive rats. (Q37648622) (← links)
• New class of agents for treatment of hypertension: Focus on direct renin inhibition (Q37801292) (← links)
• Nitric oxide: orchestrator of endothelium-dependent responses (Q37927098) (← links)
• The role of renin inhibition in treating the hypertensive patient with diabetes: a summary of preclinical and clinical evidence (Q37980260) (← links)
• Aliskiren improves endothelium-dependent relaxation of thoracic aorta by activating PI3K/Akt/eNOS signal pathway in SHR. (Q40067806) (← links)
• Aliskiren prevents and ameliorates metabolic syndrome in fructose-fed rats. (Q40418079) (← links)
• Vascular responses to 8-nitro-cyclic GMP in non-diabetic and diabetic mice (Q42002822) (← links)
• Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice (Q42006157) (← links)
• Assessment of glucagon-like peptide-1 analogue and renin inhibitor on the binding and regulation of GLP-1 receptor in type 1 diabetic rat hearts. (Q42121004) (← links)
• Metallothionein deficiency exacerbates diabetic nephropathy in streptozotocin-induced diabetic mice (Q46979061) (← links)
• Aliskiren protects against myocardial ischaemia-reperfusion injury via an endothelial nitric oxide synthase dependent manner (Q47369456) (← links)
• The direct renin inhibitor aliskiren improves vascular remodelling in transgenic rats harbouring human renin and angiotensinogen genes (Q56985191) (← links)
• Telmisartan Attenuates Diabetic Nephropathy by Suppressing Oxidative Stress in db/db Mice (Q58366410) (← links)
• Telmisartan is effective to ameliorate metabolic syndrome in rat model - a preclinical report (Q60305219) (← links)
• Aliskiren reduced renal fibrosis in mice with chronic ischemic kidney injury--beyond the direct renin inhibition (Q82534369) (← links)
• Amlodipine enhances amelioration of vascular insulin resistance, oxidative stress, and metabolic disorders by candesartan in metabolic syndrome rats (Q83663957) (← links)
• Direct renin inhibitor prevents and ameliorates insulin resistance, aortic endothelial dysfunction and vascular remodeling in fructose-fed hypertensive rats (Q84805221) (← links)
• The use of aliskiren as an antifibrotic drug in experimental models: A systematic review (Q89110295) (← links)
• The Vascular Consequences of Metabolic Syndrome: Rodent Models, Endothelial Dysfunction, and Current Therapies (Q90478656) (← links)